Data Management

Regulations that apply across geographic borders can provide researchers and patients a firmer foundation on data protection.

Final presentation at DIA reminds: "we are all patients."

Despite prevalent use in electronic devices, NRS and VAS are often implemented suboptimally.

Study shows more support is needed for clinical teams to ‘FAIRify’ their data.

Survey results emphasize need for flexibility in strategies.

Accelerating trends in clinical data are forcing changes in strategy.

Greater flexibility in eCOA solution could reduce need for backups.

How these tools can help expand capacity while maintaining compliance.

Pandemic aside, remote solutions are advancing care in clinical trials.

Martin Gouldstone, Global SVP, business development, Owkin, speaks to ACT on the use of AI in data practices and approaches for clinical research, and the distinction of “ethical AI."

Remote inspection and ICH guidelines among topics discussed at Veeva's most recent TMF Innovation Forum.

Presenting how data transformation is measured as part of the SAFE Data Standard, which data variables influence the rating and, how the appropriate level of data transformation is calculated.

Data is the heart of clinical trials, so life sciences firms need to integrate their technology to keep data sources and trial portfolios up-to-date and secure.

How management of trials must evolve.

Stakeholders from across the industry must discuss ownership to ensure effective implementation.

With an AI-enabled virtual assistant as part of your clinical research toolkit, deriving insights from clinical data is as simple as asking a question.

Improving receptivity and response to the evolving nature of clinical trial patient oversight.

Embracing patient empowerment in data collection can lead to new standard of care.

Improvements in data management and collaboration forge path to greater efficiency.

Cloud-based clinical metadata repositories can aid in accelerating clinops.

Advances in technology open door for improved EHR to EDC transfer process.

A discussion of the regulatory history behind audit trails and its interpretation as it relates to clinical research data originating or residing in EDC or eCOA systems.

Growing availability of RWD leads new drug development process.

Push for accurate data collection during pandemic led by increased focus on patient engagement.

In this interview, Heather Kopetskie, Director of Biostatistics for Rho, discusses some points related to proactively managing the many “e”s in data collection.

2020 Tufts CSDD – IBM Watson Health benchmarking study highlights need for new functionality from EDC solutions and providers.

To have a successful integration of data from across clinical systems, a strong understanding of the data is a critical.

Benefits of business 4.0 approach in EDC in med-dev studies.

Spotlight on clinical trials created by COVID-19 pandemic has forced regulatory officials around the world to expand disclosure requirements on results.

The right person can successfully promote proper management of quality and compliance, leading to desired clinical trial outcomes.